SecBot SecBot
SECBOTREPLAY Home › Report › KYMR

KYMR · Jeremy Chadwick, an officer of Kymera Therapeutics, filed a Form 144 to…

Kymera Therapeutics, Inc. · 144 filed Apr 15, 2026 at 16:41 ET

At the news

NEUTRALIMPACT 3/10

144 filed Apr 15, 2026 at 16:41 ET

Jeremy Chadwick, an officer of Kymera Therapeutics, filed a Form 144 to notify the SEC of his intent to sell 1,300 shares of common stock, representing a small portion of his holdings. This is part of a broader 10b5-1 trading plan, following a series of prior sales totaling over $14.6M in the past month.

  • Jeremy Chadwick, an officer of Kymera Therapeutics, filed Form 144 to propose selling 1,300 shares.
  • The shares are common stock, to be sold on or after April 15, 2026, via Morgan Stanley Smith Barney LLC.
  • This filing is part of an existing 10b5-1 plan, with recent sales by Chadwick totaling approximately $14.6 million over the past month.
  • The proposed sale is relatively small compared to prior transactions and the company's $7.3B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access